Rocatinlimab, an OX40 inhibitor, continues to provide results in patients with moderate to severe atopic dermatitis (AD) even after the...

Findings from a literature review suggest there is a potential role for nutritional supplements and dietary interventions in the...

AD severity is associated with incremental societal costs in Sweden.

Minor facial scars have little or no effect on ratings of attractiveness and would not benefit from revision, according to the results of...

In a study of RAS gene mutations in squamous cell carcinoma, researchers have found that a single mutated gene in an otherwise healthy...

According to a new study, topical calcineurin inhibitors such as pimecrolimus and tacrolimus did not increase risk in AD patients.

An assessment of various types of skin moisturizers suggests an emollient emulsion may be the most effective option to help prevent...

Findings from a case-control study show that a history of indoor tanning is the strongest risk factor for the development of multiple...